Skip to main content

Table 1 Characteristics of the patients at baseline

From: Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR)

Characteristics of the Patients at Baseline Total population (n = 257) SR-group (n = 148) AF-group (n = 109) p Value
Age — yr 80.8 ± 6.0 80.6 ± 6.0 80.9 ± 6.0 0.736
Male sex — no. (%) 118 (45.9%) 62 (41.9%) 56 (51.4%) 0.163
Body-mass index (kg/m2) 28.2 ± 5.5 28.3 ± 5.6 28.1 ± 5.3 0.724
Diabetes mellitus (n. %) 110 (42.8%) 57 (38.5%) 53 (48.6%) 0.126
Diabetes treated with insulin 68 (26.5%) 33 (22.3%) 35 (32.1%) 0.087
Hypertension 223 (86.8%) 126 (85.1%) 97 (89.0%) 0.457
Dyslipidemia (n. %) 179 (69.6%) 102 (68.9%) 77 (70.6%) 0.785
PAD 40 (15.6%) 17 (11.5%) 23 (21.1%) 0.038
Chronic obstructive pulmonary disease (n %) 50 (19.5%) 33 (22.3%) 17 (15.6%) 0.204
Medical history — no. (%)
Chronic kidney disease on dialysis 8 (3.1%) 7 (4.7%) 1 (0.9%) 0.143
History of cancer 64 (24.9%) 40 (27.0%) 24 (22.0%) 0.384
Active cancer 20 (7.8%) 10 (6.8%) 10 (9.2%) 0.489
Coronary heart disease 210 (81.7%) 120 (81.1%) 90 (82.6%) 0.871
Coronary-artery bypass surgery 36 (14.0%) 18 (12.2%) 18 (16.5%) 0.365
Myocardial infarction 30 (11.7%) 15 (10.1%) 15 (13.8%) 0.433
PCI 67 (26.1%) 42 (28.4%) 25 (22.9%) 0.389
Pacemaker 32 (12.5%) 11 (7.4%) 21 (19.3%) 0.007
Stroke 40 (15.6%) 22 (14.9%) 18 (16.5%) 0.731
NYHA III 164 (63.8%) 96 (64.9%) 68 (62.4%) 0.695
NYHA IV 61 (23.7%) 31 (20.9%) 30 (27.5%) 0.238
  1. All values correspond to the mean ± standard deviation or the number n (proportion in %). PAD was defined as claudication intermittens or any symptom corresponding to ≥ Fontaine stage II and / or as amputation in the context of an arterial occlusion and/or present or planned endovascular intervention for the revascularization of the peripheral vessels